Literature DB >> 30591455

Twist1 Correlates With Epithelial-Mesenchymal Transition Markers Fibronectin and Vimentin in Adrenocortical Tumors.

Daniel Bulzico1,2, Bruno Ricardo Barreto Pires3, Paulo Antônio Silvestre DE Faria4, Leonardo Vieira Neto5, Eliana Abdelhay3.   

Abstract

BACKGROUND/AIM: Although the knowledge regarding adrenocortical carcinomas (ACC) tumorigenesis has significantly improved during the last decade, it still remains to be completely determined. Epithelial-mesenchymal transition (EMT) is a well described transcription factor induced process, postulated as an essential step toward cancer progression and metastasis development. In this context, Twist1 has been described as the EMT master-regulator. The aim of this study was to assess the association among Twist1, fibronectin, vimentin and E-cadherin gene expression in adrenocortical tumor samples.
MATERIALS AND METHODS: Twist1, fibronectin, vimentin and E-cadherin gene expression in 18 adrenal adenomas, 18 ACC, and 24 childhood onset adrenocortical tumors were assessed in formalin-fixed paraffin-embedded tissues. The fold expression was calculated according to the 2ΔCt method.
RESULTS: A significant correlation between mRNA levels of Twist1, fibronectin and vimentin was evident. Although their expression was inversely proportional, no association was observed between Twist1 and E-cadherin expression.
CONCLUSION: The expression of Twist1, the major regulator of EMT, is directly correlated to the expression of mesenchymal markers fibronectin and vimentin in ACC samples. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Adrenocortical carcinoma; epithelial-mesenchymal transition; transcriptional factor

Mesh:

Substances:

Year:  2019        PMID: 30591455     DOI: 10.21873/anticanres.13094

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells by blocking the activation of p65 and p38MAPK.

Authors:  Yonggang He; Xuehui Peng; Lu Zheng; Yichen Tang; Jing Li; Xiaobing Huang
Journal:  J Gastrointest Oncol       Date:  2021-02

2.  Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting.

Authors:  Chaosheng Yu; Fang Chen; Xiaoqi Wang; Zhimou Cai; Mengxue Yang; Qingwen Zhong; Jialian Feng; Junzheng Li; Congxiang Shen; Zhong Wen
Journal:  J Exp Clin Cancer Res       Date:  2020-02-07

Review 3.  The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives.

Authors:  Maja Mizdrak; Tina Tičinović Kurir; Joško Božić
Journal:  Biomedicines       Date:  2021-02-10

4.  Twist1 regulates macrophage plasticity to promote renal fibrosis through galectin-3.

Authors:  Qingfeng Wu; Shiren Sun; Lei Wei; Minna Liu; Hao Liu; Ting Liu; Ying Zhou; Qing Jia; Di Wang; Zhen Yang; Menglu Duan; Xiaoxia Yang; Peisong Gao; Xiaoxuan Ning
Journal:  Cell Mol Life Sci       Date:  2022-02-19       Impact factor: 9.207

5.  N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1.

Authors:  Chenliang Zhou; Zhichang Zhang; Xiaoshi Zhu; Guowei Qian; Yan Zhou; Yong Sun; Wenxi Yu; Jiahui Wang; Haiyang Lu; Feng Lin; Zan Shen; Shuier Zheng
Journal:  EBioMedicine       Date:  2020-08-24       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.